Showing results (2161-2170 of 2,378) with videos related to

Sort By:
Pageof 238
Cancer Research|August 29, 2020
Integrated Genomic Characterization of the Human Immunome in CancerYongsheng Li, Brandon Burgman, Daniel J McGrail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2011
Phase I dose-escalation study of the pan-HER inhibitor, PF299804, in patients with advanced malignant solid tumorsPasi A Jänne, David S Boss, D Ross Camidge, et al.
Natural Product Research|September 29, 2025
Antibacterial cyclopentenones from the coprophilous fungus Clonostachys pseudochroleucaAnnick B F Kapche, Paul Eckhardt, Joseph Tchamgoue, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 19, 2025
TNFR2 signaling shapes the sex-specific remyelinating properties of microglia after experimental strokeStefano Raffaele, Francesca Carolina Mannella, Estrid Thougaard, et al.
The Journal of Applied Laboratory Medicine|May 24, 2020
Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and DiabetesKatherine L O'Grady, Sundeep Khosla, Joshua N Farr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A phase I, pharmacokinetic, and biological study of the farnesyltransferase inhibitor tipifarnib in combination with gemcitabine in patients with advanced malignanciesAmita Patnaik, S Gail Eckhardt, Elzbieta Izbicka, et al.
Frontiers in Oncology|April 19, 2021
WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal AdenocarcinomaSarah J Hartman, Stacey M Bagby, Betelehem W Yacob, et al.
Acta Neuropathologica|September 10, 2024
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significanceLotte Stegat, Alicia Eckhardt, Antonia Gocke, et al.
Neuro-Oncology|October 11, 2023
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastomaAlicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Oncotarget|October 7, 2015
Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenograftsChristopher H Lieu, Peter J Klauck, Patrick K Henthorn, et al.
Pageof 238